Predictive Oncology Inc.

@flaatty (Please send a DM and we will work to resolve this. We were aware of problems with the last call, but not previous ones. Thank you.)

@flaatty Peter, please let us know what happened in calls past and we will address it with the company that supports our shareholder calls. We want to make sure this is not an issue moving forward.

We wanted to extend our apologies for the technical difficulties with the shareholder call yesterday.If you weren’t able to connect for questions, we look forward to further discussion during a Townhall we're planning after Thanksgiving & will keep you posted w/details. $POAI 1/2

We appreciate the open dialogue and look forward to this new chapter for Predictive Oncology. $POAI 2/2

Shareholders, if you are hoping to ask questions during our webcast, please register at this link. $POAI register.vevent.com/register/BI5f7…

@IncendioLSX Absolutely! This is a fantastic appointment because Raymond has the vision and experience to propel our business growth forward. He brings a fresh perspective and understands how our products fit into the industry.

Predictive Oncology appoints Raymond F. Vennare as CEO. An accomplished senior executive in life sciences, Mr. Vennare brings more than three decades of experience building and launching innovative biotechnology companies. Read more here: hubs.la/Q01qgNsH0. $POAI

Recently, our SVP Pamela Bush, Ph.D. sat down with @CheckRare to share insight into our Proof of Concept Study—which demonstrated that our PeDAL platform can predict a tumor’s response to a drug with 92% accuracy. Check it out here: checkrare.com/using-artifici…

We're gearing up for the Augmented Intelligence (AI) in Drug Discovery Xchange in San Francisco this Friday. Predictive Oncology SVP Pamela A. Bush, Ph.D., will be on hand to deliver the keynote and network with attendees. Will we see you there? hubs.la/Q01n35Tm0

Recently, we put our PeDAL platform to the test to prove its value as a tool for AI-driven drug discovery. This hands-on testing revealed exciting results. Get an advanced look at this impressive Proof of Concept report here: hubs.la/Q01n063-0

We wish our best to CEO Mel Engle as he announces his retirement, effective Oct. 31. Mel has played an instrumental role in setting up Predictive Oncology for the next stage of growth. This includes several key developments to further strengthen our offerings in drug development.

@MLBsux Thanks for asking. Please join us for the call on Friday, August 12, at 12:00 PM ET. You can register for the webcast: edge.media-server.com/mmc/p/it32fi7n. For Q&A’s, please register here: register.vevent.com/register/BI2e8…

Please join us for a shareholder earnings call on Friday, August 12, at 12:00 PM ET. To register and view the webcast, please go to this link: edge.media-server.com/mmc/p/it32fi7n. For Q&A’s, please register here: register.vevent.com/register/BI2e8… $POAI

Predictive Oncology strengthens business and product offerings with the appointment of Chief Scientific Officer, Julia Kirshner, Ph.D., and consolidation and expansion of its research and development arm. $POAI investors.predictive-oncology.com/news-releases/…

We are driven by the impact we have in reducing risk & moving candidates forward confidently with 3D cell culture technology. We're producing more reliable outcomes in drug development and advancing anticancer drug candidates with our zPREDICTA line & Labcorp partnership. $POAI

At the heart of POAI is a team of people who share a dedication in the fight against cancer. Some affected personally-themselves or with others. Behind the business side is a deep motivation. We are in this for the long run. This is just one story of many. linkedin.com/posts/prmarket…

Congratulations to Predictive Oncology's own Dr. Larry DeLucas for being named to the Top 50 Over 50! While we know Dr. DeLucas is talented beyond measure, we appreciate it when our leaders are recognized by others for their many achievements. $POAI #top50over50 #drugdevelopment

@Nate34963600 For all of our products, especially the AI technology we have paired with the 150K tumor samples (via our validated PeDAL platform).

@PredictiveOnc Were partnerships discussed for all POAI subsidiaries or just Soluble Biotech?

From partnering meetings to networking events, the Predictive Oncology team represented at BIO International in San Diego this week. Our SVP of Strategic Sales and Business Development, Dr. Pamela Bush, was even interviewed for the I am BIO podcast & a BIO video. #BIO2022 $POAI

@flaatty We are excited, too! We've had some great conversations on the first day and look forward to many more. Thanks for your support.

@PredictiveOnc I’m excited to see where you can take this. Getting the attention of the industry should be very lucrative for the company.

BIO International kicked off yesterday and our team was in full force networking and meeting with companies that can use our technologies to advance the drug discovery process. Today is Day 2 & we are ready to roll! DM us to connect if you're here. $POAI #BIO2022 #pharma